Cytokinetics
Kyle Jennings has extensive experience in clinical trial management, currently serving as Clinical Trial Manager II at Cytokinetics since August 2017, where responsibilities include preparing and tracking Investigational Product shipments and managing document reviews. Previously, Kyle held roles at Gilead Sciences as a Clinical Project Assistant, maintaining Trial Master Files, and at The Maas Clinic as a Clinical Research Assistant, assisting with data analysis in phase III and IV clinical trials. Earlier career experiences include positions in pharmaceutical manufacturing at Genentech and various roles in personal training. Kyle holds a Bachelor of Science degree in Kinesiology and Exercise Science from Florida State University, completed in 2014.
This person is not in any teams
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.